Calypte Biomedical (Lake Oswego, Oregon), on Friday issued a statement saying that it will hold a conference call tomorrow (Sept. 18) “to discuss a significant corporate development” and will issue a statement concerning that development before the opening of the stock market on that day.

The conference call will take place at 10:30 a.m., EST.

Calypte develops rapid testing products for sexually transmitted diseases, such as the Aware HIV-1/2 OMT test, suitable for use at the point of care and at home.